Imaging & Diagnostics

5-year ATOM2 trial data confirms that 0.01% atropine is more effective at slowing myopia progression than 0.1% and 0.5% doses

Trypan blue is usually the dye of choice for anterior segment surgeons – but how did it become the king of vital dyes?

Celebrating its 25th anniversary at the American Academy of Ophthalmology (AAO) Meeting in Las Vegas, Heidelberg Engineering will present its latest diagnostic imaging technologies and services. For a quarter of a century, the company has been committed to delivering solutions to fundamental clinical needs in ophthalmology.

Creative approaches and specialized visual acuity measurements can lead to success in presbyopic lens surgery

Peripheral retinal lesions may predict diabetic patients’ risk of disease progression – and ultrawide field imaging could enable a better and earlier early diagnosis

The feedback and reactions to the first public presentation of Heidelberg Engineering’s new Cataract and Refractive Imaging Platform* at the ESCRS in Barcelona were extremely positive. Many leading ophthalmologists visited Heidelberg Engineering’s booth for a hands-on preview of the swept-source OCT Cataract and Refractive Imaging Platform and had the chance to experience its versatility. Have a look at this Eyewire TV to find out more.

What if there was an imaging technique that could detect retinal disease processes before any structural damage had even occurred?

Heidelberg Engineering will offer a preview of its cataract and refractive imaging platform* during this year’s Congress of the ESCRS in Barcelona. The platform is based on an upgradable, modular design, which allows to configure each product to the specific diagnostic workflow in a practice or clinic. Main options include: IOL biometry, corneal topography/tomography, anterior segment biometry and anterior segment imaging.

Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology.

A new ocular biometer automates IOL selection and offers an exciting alternative to sometimes unpredictable IOL power formulae